Drug Shortage Report for MYLAN-OMEPRAZOLE

Last updated on 2020-04-22 History
Report ID 19496
Drug Identification Number 02329433
Brand name MYLAN-OMEPRAZOLE
Common or Proper name OMEPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) OMEPRAZOLE
Strength(s) 20MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100BT, 500BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-09-08
Actual start date 2017-09-11
Estimated end date Unknown
Actual end date 2018-12-20
Shortage status Resolved
Updated date 2020-04-22
Company comments Discontinued in ID 48569
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2020-04-22 English Compare
v29 2018-05-04 French Compare
v28 2018-05-04 English Compare
v27 2018-04-13 French Compare
v26 2018-04-13 English Compare
v25 2018-03-19 French Compare
v24 2018-03-19 English Compare
v23 2018-01-17 French Compare
v22 2018-01-17 English Compare
v21 2017-10-13 French Compare
v20 2017-10-13 English Compare
v19 2017-10-05 French Compare
v18 2017-10-05 English Compare
v17 2017-09-13 French Compare
v16 2017-09-13 English Compare
v15 2017-09-09 English Compare
v14 2017-09-08 French Compare
v13 2017-09-08 English Compare
v12 2017-09-08 English Compare
v11 2017-09-05 English Compare

Showing 1 to 20 of 30